Review: Utility of mass spectrometry in rare disease research and diagnosis

Maher, S., Jjunju, F. P. M. & Taylor, S. Colloquium: 100 years of mass spectrometry: perspectives and future trends. Rev. Mod. Phys. 87, 113–135 (2015).

Article  CAS  Google Scholar 

Griffiths, J. A brief history of mass spectrometry. Anal. Chem. 80, 5678–5683 (2008).

Article  CAS  PubMed  Google Scholar 

Parkins, W. & E, W. The uranium bomb, the calutron, and the space-charge problem. Phys. Today 58, 45–51 (2005).

Article  CAS  Google Scholar 

Pitt, J. J. Principles and applications of liquid chromatography-mass spectrometry in clinical biochemistry. Clin. Biochem. Rev. 30, 19–34 (2009).

PubMed  PubMed Central  Google Scholar 

Aebersold, R. & Mann, M. Mass spectrometry-based proteomics. Nature 422, 198–207 (2003).

Article  CAS  PubMed  Google Scholar 

Nkuipou-Kenfack, E., Zurbig, P. & Mischak, H. The long path towards implementation of clinical proteomics: exemplified based on CKD273. Proteomics Clin. Appl. 11 (2017).

Roos, A., Thompson, R., Horvath, R., Lochmuller, H. & Sickmann, A. Intersection of proteomics and genomics to “solve the unsolved” in rare disorders such as neurodegenerative and neuromuscular diseases. Proteomics Clin. Appl. 12 (2018).

Braconi, D., Bernardini, G., Spiga, O. & Santucci, A. Leveraging proteomics in orphan disease research: pitfalls and potential. Expert Rev. Proteom. 18, 315–327 (2021).

Article  CAS  Google Scholar 

Chantada-Vazquez, M. D. P., Bravo, S. B., Barbosa-Gouveia, S., Alvarez, J. V. & Couce, M. L. Proteomics in inherited metabolic disorders. Int. J. Mol. Sci. 23, 14744 (2022).

Suran, M. After the genome-a brief history of proteomics. JAMA 328, 1168–1169 (2022).

Article  PubMed  Google Scholar 

Hartin, S. N., Means, J. C., Alaimo, J. T. & Younger, S. T. Expediting rare disease diagnosis: a call to bridge the gap between clinical and functional genomics. Mol. Med. 26, 117 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Wojcik, M. H. et al. Genome sequencing for diagnosing rare diseases. N. Engl. J. Med. 390, 1985–1997 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kopajtich, R. et al. Integration of proteomics with genomics and transcriptomics increases the diagnostic rate of Mendelian disorders. Preprint at medRxiv 2021.03.09.21253187 (2021).

Hock, D. H. et al. Untargeted proteomics enables ultra-rapid variant prioritization in mitochondrial and other rare diseases. Preprint at medRxiv 2024.08.06.24311318 (2024).

Cui, M., Cheng, C. & Zhang, L. High-throughput proteomics: a methodological mini-review. Lab Invest. 102, 1170–1181 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Fredriksson, S. et al. Protein detection using proximity-dependent DNA ligation assays. Nat. Biotechnol. 20, 473–477 (2002).

Article  CAS  PubMed  Google Scholar 

Rodari, M. M. et al. Insights into the expanding intestinal phenotypic spectrum of SOCS1 haploinsufficiency and therapeutic options. J. Clin. Immunol. 43, 1403–1413 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu, F. et al. Loss of the TRPM4 channel in humans causes immune dysregulation with defective monocyte migration. J. Allergy Clin. Immunol. 154, 792–806 (2024).

Article  CAS  PubMed  Google Scholar 

Deng, Y. T. et al. Atlas of the plasma proteome in health and disease in 53,026 adults. Cell 188, 253–271.e7 (2024).

Stark, Z. et al. A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders. Genet. Med. 18, 1090–1096 (2016).

Article  CAS  PubMed  Google Scholar 

Tan, T. Y. et al. Diagnostic impact and cost-effectiveness of whole-exome sequencing for ambulant children with suspected monogenic conditions. JAMA Pediatr. 171, 855–862 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Stark, Z. et al. Australian genomics: outcomes of a 5-year national program to accelerate the integration of genomics in healthcare. Am. J. Hum. Genet. 110, 419–426 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kremer, L. S. et al. Genetic diagnosis of Mendelian disorders via RNA sequencing. Nat. Commun. 8, 15824 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yépez, V. A. et al. Detection of aberrant gene expression events in RNA sequencing data. Nat. Protoc. 16, 1276–1296 (2021).

Article  PubMed  Google Scholar 

Alston, C. L. et al. Bi-allelic mutations in NDUFA6 establish its role in early-onset isolated mitochondrial complex I deficiency. Am. J. Hum. Genet. 103, 592–601 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sbardella, D. et al. Defective proteasome biogenesis into skin fibroblasts isolated from Rett syndrome subjects with MeCP2 non-sense mutations. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165793 (2020).

Article  CAS  PubMed  Google Scholar 

Frazier, A. E. et al. Fatal perinatal mitochondrial cardiac failure caused by recurrent de novo duplications in the ATAD3 locus. Med 2, 49–73 (2021).

Article  CAS  PubMed  Google Scholar 

Helman, G. et al. Multiomic analysis elucidates Complex I deficiency caused by a deep intronic variant in NDUFB10. Hum. Mutat. 42, 19–24 (2021).

Article  CAS  PubMed  Google Scholar 

Sathe, G. et al. Ethylmalonic encephalopathy ETHE1 p. D165H mutation alters the mitochondrial function in human skeletal muscle proteome. Mitochondrion 58, 64–71 (2021).

Article  CAS  PubMed  Google Scholar 

Lee, R. G. et al. Deleterious variants in CRLS1 lead to cardiolipin deficiency and cause an autosomal recessive multi-system mitochondrial disease. Hum. Mol. Genet. 31, 3597–3612 (2022).

Rahman, S. Leigh syndrome. Handb. Clin. Neurol. 194, 43–63 (2023).

Article  PubMed  Google Scholar 

Lake, N. J. et al. Biallelic mutations in MRPS34 lead to instability of the small mitoribosomal subunit and Leigh syndrome. Am. J. Hum. Genet. 101, 239–254 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alahmad, A. et al. Bi-allelic pathogenic variants in NDUFC2 cause early-onset Leigh syndrome and stalled biogenesis of complex I. EMBO Mol. Med. 12, e12619 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alston, C. L. et al. Pathogenic bi-allelic mutations in NDUFAF8 cause Leigh syndrome with an isolated complex I deficiency. Am. J. Hum. Genet. 106, 92–101 (2020).

Article  CAS  PubMed  Google Scholar 

Feldkirchner, S. et al. Proteomic characterization of aggregate components in an intrafamilial variable FHL1-associated myopathy. Neuromuscul. Disord. 23, 418–426 (2013).

Article  PubMed  Google Scholar 

Van Bergen, N. J. et al. Mutations in the exocyst component EXOC2 cause severe defects in human brain development. J. Exp. Med. 217, e20192040 (2020).

Foehr, R., Anderson, K., Dombrowski, O., Foehr, A. & Foehr, E. D. Dysregulation of extracellular matrix and lysyl oxidase in Ehlers-Danlos syndrome type IV skin fibroblasts. Orphanet J. Rare Dis. 19, 9 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Lunke, S. et al. Integrated multi-omics for rapid rare disease diagnosis on a national scale. Nat. Med. 29, 1681–1691 (2023).

Amarasekera, S. S. C. et al. Multi-omics identifies large mitoribosomal subunit instability caused by pathogenic MRPL39 variants as a cause of pediatric onset mitochondrial disease. Hum. Mol. Genet. 32, 2441–2454 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bakhshalizadeh, S. et al. Deficiency of the mitochondrial ribosomal subunit, MRPL50, causes autosomal recessive syndromic premature ovarian insufficiency. Hum. Genet. 142, 879–907 (2023).

Article  CAS 

Comments (0)

No login
gif